1 Followers HKEX:3347 - Hangzhou Tigermed Consulting Co Ltd Hangzhou Tigermed Consulting C
Sector: Health Care, Industry: Life Sciences Tools & Services
Next Earnings: 23 Apr 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

HKD 29.6    +0.55 (+1.89%)

28 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D.

Headquarters: HK

Employees: 9,233

Homepage

Description

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms